The phospholipid-bound krill alternative for fish-oil-intolerant buyers.
Onnit Krill Oil is the bottle to consider when you've tried fish oil — even premium TG-form — and the burp profile still drives you to quit before bottle 1 finishes. At $36 for 60 softgels (1-2 months depending on dose), it ships Antarctic-sourced krill oil delivering EPA + DHA bound to phospholipids (not the triglyceride form found in fish oil) plus astaxanthin antioxidant co-factor. The phospholipid-bound format produces a dramatically better burp profile than even the cleanest fish oil and a modestly better absorption per mg (10-20%, not the 'dramatically superior' marketing framing).
The catch: at ~250 mg combined EPA+DHA per softgel, you're paying roughly 3× the $/gram of EPA+DHA vs fish-oil picks. Eight weeks running 2 softgels/day with breakfast, here's the breakdown.
Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Omega-3 guide →Phospholipid-bound EPA + DHA (krill oil format) at ~250 mg combined per softgel. The phospholipid format provides a small absorption advantage per mg (~10-20% vs triglyceride) but per-cap absolute dose is dramatically lower than fish-oil triple-strength competitors (1200-1600 mg/cap). Reaching clinical dose requires 4-8 caps/day — expensive at the $/g math.
Third-party tested under Onnit's QC program — heavy-metal screening and potency verification. Not IFOS-certified (IFOS is primarily a fish-oil standard; krill oil testing falls under different protocols). Antarctic krill has very low contaminant bioconcentration naturally — krill are at the lowest trophic level, eating phytoplankton, with virtually no mercury or PCB exposure.
Antarctic krill harvested under CCAMLR management — quotas at ~1% of estimated biomass annually. Most major krill brands (including Onnit's supplier) hold MSC certification for the Antarctic krill fishery. The ecosystem concern is long-term (krill are the foundation of the Antarctic food chain) but current management is conservative.
$36/month at ~500 mg EPA+DHA/day (2 softgels) = ~$2.40/g of EPA+DHA — the most expensive per-gram on the entire 10-pick list. Reaching the clinical 1-2 g/day window costs $70-150/month at krill prices. The $/g math is genuinely poor — phospholipid format and astaxanthin don't justify the 3× premium for most users.
Best burp profile on the entire 10-pick list — phospholipid-bound krill oil produces virtually zero fishy repeat even at 4+ caps/day on an empty stomach. Smaller softgel size than fish-oil triple-strength competitors. Krill oil also doesn't carry the marine-oil aftertaste that even premium fish oil has. The format advantage is real and meaningful for sensitive users.
“Phospholipid-bound omega-3 — superior bioavailability.”
The phospholipid-bound bioavailability claim is mechanistically real but practically modest. Ulven 2011 and Maki 2009 measured roughly equivalent or 10-20% higher Omega-3 Index increase from krill vs fish oil at equivalent EPA+DHA doses — meaningful but not 'dramatically superior' as some krill marketing implies. Onnit's framing is on the right side of the truth, slightly overstated.
“Antarctic-sourced — pure, pollutant-free krill.”
Antarctic krill is harvested at the southern-ocean ecosystem with virtually no industrial-pollution contamination. Krill themselves are at the lowest trophic level (eating phytoplankton), so mercury and PCB bioconcentration is near-zero. Sourcing claim is real and the lowest-contaminant marine omega-3 source available.
“Includes astaxanthin antioxidant.”
Krill oil naturally contains ~80-300 µg of astaxanthin per gram — a genuine carotenoid antioxidant that also stabilises the oil against oxidation. The per-cap dose is below most dedicated astaxanthin supplement protocols (4-12 mg/day) but provides real oil-stability benefit. Honest claim.
“Supports joint, heart, and brain health.”
All three are real omega-3 effects backed by the broader EPA+DHA literature (Mozaffarian 2008 cardiovascular, Serhan 2014 resolvin-driven anti-inflammatory, Yurko-Mauro 2010 cognition). The framing is accurate in spirit but the per-cap EPA+DHA dose (250 mg) is low enough that reaching clinical effect requires 4+ caps/day. Standard marketing simplification.
“Sustainably harvested under CCAMLR management.”
Onnit's krill supplier is under CCAMLR quotas with MSC chain-of-custody certification. CCAMLR manages the Antarctic krill fishery with conservative quotas (~1% of estimated biomass annually). Real, auditable sustainability claim — better than uncertified fish-oil sources, comparable to MSC-certified fish picks like Wiley's Finest (#6).
Krill oil delivers EPA and DHA bound to phospholipid molecules (vs the triglyceride backbone in fish oil). Mechanistically, phospholipids integrate directly into cell membranes without requiring lipase hydrolysis — which sounds like it should produce dramatically better absorption. In practice, head-to-head comparative bioavailability studies (Ulven 2011, Maki 2009) show roughly equivalent or 10-20% higher Omega-3 Index increase from krill vs fish oil at the same EPA+DHA dose. The advantage is real but small — it doesn't justify the 3× $/g price premium for most users.
Onnit Krill at $0.60/cap delivers ~250 mg combined EPA+DHA. Reaching the 1-2 g/day general-health window costs $72-144/month from krill alone. The same dose from Nordic Naturals fish oil (#1) costs $38-76/month. That's a $30-70/month additional cost specifically for the krill format — meaningful budget impact across a year of use. The math only works if (a) fish oil burps are intolerable to you despite premium TG-form brands or (b) you specifically want astaxanthin in the formulation.
If there's one thing krill oil indisputably wins on, it's the burp profile. Phospholipid-bound omega-3 doesn't produce the marine-oil reflux that even premium fish oil triggers in sensitive users. Combined with the smaller softgel size (compared to fish-oil triple-strength) and the astaxanthin-driven oxidation stability, the format is the cleanest-tolerated marine omega-3 on the market. For users who've quit fish oil multiple times because of burps regardless of brand, krill is the legitimate answer despite the price.
Common mistake: people start with fish oil, can't tolerate the burps, add krill oil thinking it'll help. The right approach is to choose one — krill OR fish oil — based on tolerance. If fish oil works for you, the $/g math heavily favours staying with it. If fish oil doesn't work regardless of brand or format, switch entirely to krill. Stacking both is double-paying for the same actives without doubling the effect; the absorption ceilings overlap.
Krill are crustaceans (tiny shrimp-like creatures), and krill oil contains residual crustacean proteins that can trigger reactions in shellfish-allergic users. Most krill oil is processed to minimise allergenic protein content, but documented allergic reactions are real and well-reported in the literature. Absolute rule: if you have any documented shellfish allergy, do not buy krill oil regardless of how 'cleaned' the product claims to be. Algae-source omega-3 (Ovega-3 #10) is the safe alternative for shellfish-allergic users — same actives, zero crustacean exposure.
Onnit Krill Oil is what we recommend to a very specific buyer: someone who's tried premium triglyceride-form fish oil (Nordic Naturals, Carlson, Wiley's Finest) and still finds the burp profile intolerable enough to quit before bottle 1 finishes. Krill oil's phospholipid-bound format produces dramatically less marine-oil reflux than even the cleanest fish oil, plus the smaller softgel size and astaxanthin oxidation stability compound the tolerance advantage. For this niche of buyers, krill is genuinely the right answer. For everyone else, the dose-per-dollar math is brutal. At $2.40/g of EPA+DHA — 3× the cost of fish-oil picks at similar quality — Onnit Krill requires you to pay $70-140/month to reach the clinical 1-2 g/day dose that fish oil delivers at $20-40/month. The phospholipid-bound absorption advantage (~10-20%) doesn't compensate for the 3× pricing premium. Pick krill specifically when fish-oil intolerance is the driver; default to fish-oil picks (#1-#8) when it isn't. And if you have shellfish allergy, default to algae-source Ovega-3 (#10) — same actives, zero crustacean exposure.
The shellfish-allergy-safe alternative at $42/month — algae-sourced EPA+DHA with zero crustacean exposure. Right pick if you have shellfish allergy or want vegan-certified source.
See it on the list →The fish-oil default at $38/month — rTG form, IFOS 5-star, lemon-flavoured caps. The right answer for most omega-3 buyers at one-third the krill $/g cost.
See it on the list →The MSC-certified wild-source alternative at $30/month — rTG fish oil with similar Antarctic-tier sustainability commitment from wild Alaskan fisheries.
See it on the list →Comprehensive omega-3 cardiovascular review — establishes 10-33% triglyceride reduction at 2-4 g/day combined EPA+DHA. Krill oil at 4-8 caps/day reaches this protocol window but at significantly higher cost than fish-oil equivalents.
Head-to-head bioavailability of TG, rTG, and EE forms — establishes the 30-50% absorption advantage of TG/rTG over EE in fish oil. Phospholipid-bound krill omega-3 sits closer to the TG/rTG absorption tier than to EE.
Defined the Omega-3 Index as a CV risk biomarker. Index of 8%+ associated with lowest CHD mortality. Krill oil at 4 caps/day for 12 weeks moves the index toward target — same endpoint as fish oil, more expensive route.
Mapped the resolvin and protectin biosynthesis pathway from EPA + DHA — the molecular mechanism behind omega-3's anti-inflammatory effect. The pathway runs identically regardless of whether EPA+DHA arrives via triglyceride or phospholipid carrier.
EPA-dominant formulations (EPA:DHA ≥60%) significantly improved depression scores; DHA-dominant did not. Krill oil's EPA:DHA ratio varies by source but typically sits ~1.5-2:1 — borderline for the Sublette threshold and not the optimal formulation for mood-protocol use.
